These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 32451712)

  • 21. Health education to promote knowledge about sickle cell disease and newborn screening in pregnant women: a community-based pilot study using the healthy beginning initiative.
    Ezenwosu OU; Olawepo JO; Lacroix-Willliamson LJ; Itanyi IU; Ogidi A; Onyeka TC; Gully M; Gregory M; Breeze JL; Ibemere S; Idemili-Aronu N; Molnar BE; Ezeanolue EE
    BMC Pregnancy Childbirth; 2024 Apr; 24(1):321. PubMed ID: 38671412
    [TBL] [Abstract][Full Text] [Related]  

  • 22. History and current status of newborn screening for hemoglobinopathies.
    Benson JM; Therrell BL
    Semin Perinatol; 2010 Apr; 34(2):134-44. PubMed ID: 20207263
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Incidence of sickle cell disease in an unselected cohort of neonates born in Berlin, Germany.
    Lobitz S; Frömmel C; Brose A; Klein J; Blankenstein O
    Eur J Hum Genet; 2014 Aug; 22(8):1051-3. PubMed ID: 24398797
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Newborn screening for sickle cell diseases in the United States: A review of data spanning 2 decades.
    Therrell BL; Lloyd-Puryear MA; Eckman JR; Mann MY
    Semin Perinatol; 2015 Apr; 39(3):238-51. PubMed ID: 25979783
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Implementation of hospital-based sickle cell newborn screening and follow-up programs in Haiti.
    Alvarez OA; St Victor Dély N; Paul Hanna M; Saint Fleur R; Cetoute M; Metalonis S; Hustace T; Brown EC; Marcelin LH; Muscadin E; Eveillard R; Lerebours E
    Blood Adv; 2024 Jan; 8(1):14-22. PubMed ID: 37820110
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Early detection of sickle cell anemia and other hemoglobinopathies in neonates in the Autonomous Community of Madrid. A pilot study].
    Dulín Iñígueza E; Cantalejo López MA; Cela de Julián ME; Galarón García P
    An Pediatr (Barc); 2003 Feb; 58(2):146-55. PubMed ID: 12628145
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Primary care follow-up of newborns with sickle cell disease detected in neonatal screening in the Community of Madrid].
    Rodríguez-Moldes B; Carbajo AJ; Sánchez B; Fernández M; Garí M; Fernández MC; Álvarez J; García A; Cela E
    An Pediatr (Barc); 2015 Apr; 82(4):222-7. PubMed ID: 24840253
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Implementing newborn screening for sickle cell disease in Korle Bu Teaching Hospital, Accra: Results and lessons learned.
    Segbefia CI; Goka B; Welbeck J; Amegan-Aho K; Dwuma-Badu D; Rao S; Salifu N; Oppong SA; Odei E; Ohene-Frempong K; Odame I
    Pediatr Blood Cancer; 2021 Jul; 68(7):e29068. PubMed ID: 33890391
    [TBL] [Abstract][Full Text] [Related]  

  • 29. New approach to accurate interpretation of sickle cell disease newborn screening by applying multiple of median cutoffs and ratios.
    Allaf B; Patin F; Elion J; Couque N
    Pediatr Blood Cancer; 2018 Sep; 65(9):e27230. PubMed ID: 29781571
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Evaluation of newborn sickle cell screening programme in England: 2010-2016.
    Streetly A; Sisodia R; Dick M; Latinovic R; Hounsell K; Dormandy E
    Arch Dis Child; 2018 Jul; 103(7):648-653. PubMed ID: 29104181
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Acceptability of Newborn Screening for Sickle Cell Disease among Post-Partum Mothers in Abakaliki, South East Nigeria.
    Nnachi OC; Umeokonkwo AA; Okoye HC; Ekwe AN; Akpa CO; Okoye AE
    West Afr J Med; 2023 Mar; 40(3):298-304. PubMed ID: 37017939
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Potential of point of care tests for newborn screening for sickle cell disease: Evaluation of HemotypeSC™ and sickle SCAN® in Tanzania.
    Christopher H; Josephat E; Kaywanga F; Saul S; Mshana I; Kunambi P; Nasser A; Chamba C; Makani J; Nkya S
    Int J Lab Hematol; 2022 Oct; 44(5):959-965. PubMed ID: 35775883
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Birth Prevalence of Sickle Cell Disease and County-Level Social Vulnerability - Sickle Cell Data Collection Program, 11 States, 2016-2020.
    Kayle M; Blewer AL; Pan W; Rothman JA; Polick CS; Rivenbark J; Fisher E; Reyes C; Strouse JJ; Weeks S; Desai JR; Snyder AB; Zhou M; Sutaria A; Valle J; Horiuchi SS; Sontag MK; Miller JI; Singh A; Dasgupta M; Janson IA; Galadanci N; Reeves SL; Latta K; Hurden I; Cromartie SJ; Plaxco AP; Mukhopadhyay A; Smeltzer MP; Hulihan M
    MMWR Morb Mortal Wkly Rep; 2024 Mar; 73(12):248-254. PubMed ID: 38547025
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A Newborn Screening Program for Sickle Cell Disease in Murcia (Spain).
    Sánchez-Villalobos M; Campos Baños E; Juan Fita MJ; Egea Mellado JM; Gonzalez Gallego I; Beltrán Videla A; Berenguer Piqueras M; Bermúdez Cortés M; Moraleda Jiménez JM; Guillen Navarro E; Salido Fierrez E; Pérez-Oliva AB
    Int J Neonatal Screen; 2023 Oct; 9(4):. PubMed ID: 37873846
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Results of the neonatal screening on Western Andalusia after a decade of experience.].
    Delgado-Pecellín C; Álvarez Ríos I; Bueno Delgado MDA; Jiménez Jambrina MM; Quintana Gallego ME; Ruiz Salas P; Marcos Luque I; Melguizo Madrid E
    Rev Esp Salud Publica; 2020 Dec; 94():. PubMed ID: 33323920
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Potential for a large-scale newborn screening strategy for sickle cell disease in Mali: A comparative diagnostic performance study of two rapid diagnostic tests (SickleScan® and HemotypeSC®) on cord blood.
    Guindo A; Cisse Z; Keita I; Desmonde S; Sarro YDS; Touré BA; Baraika MA; Tessougué O; Guindo P; Coulibaly M; Traore O; Sylla N; Diassana M; Saye A; Picot V; Lauressergues E; Leroy V
    Br J Haematol; 2024 Jan; 204(1):337-345. PubMed ID: 37728227
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Point-of-care screening for sickle cell disease in low-resource settings: A multi-center evaluation of HemoTypeSC, a novel rapid test.
    Steele C; Sinski A; Asibey J; Hardy-Dessources MD; Elana G; Brennan C; Odame I; Hoppe C; Geisberg M; Serrao E; Quinn CT
    Am J Hematol; 2019 Jan; 94(1):39-45. PubMed ID: 30290004
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Newborn Screening and Clinical Profile of Children With Sickle Cell Disease in a Tribal Area of Gujarat.
    Dave K; Desai S; Italia Y; Mukherjee MB; Mehta P; Desai G
    Indian Pediatr; 2022 Mar; 59(3):230-233. PubMed ID: 35014619
    [TBL] [Abstract][Full Text] [Related]  

  • 39. MALDI-MS in first-line screening of newborns for sickle cell disease: results from a prospective study in comparison to HPLC.
    El Osta M; Benoist JF; Naubourg P; Bonacorsi S; Messine R; Ducoroy P; Allaf B
    Clin Chem Lab Med; 2024 May; 62(6):1149-1157. PubMed ID: 38353144
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Saving lives through early diagnosis: the promise and role of point of care testing for sickle cell disease.
    Dexter D; McGann PT
    Br J Haematol; 2022 Jan; 196(1):63-69. PubMed ID: 34340260
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.